Form D — Eliaz Therapeutics Inc.
0001062993-25-016285 · filed Oct 24, 2025
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $850,000
- Total sold
- $850,000
- Minimum investment
- $100,000
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Eliaz Therapeutics Inc.
- CIK
- 2042609
- Entity
- Corporation
- Jurisdiction
- DE
- Year incorporated
- 2015
- Address
- 398 TESCONI COURT
SANTA ROSA, CA 95401 - Phone
- —
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Isaac Eliaz · Executive OfficerSanta Rosa, CA Find on LinkedIn ↗
-
Milton Goss · Executive OfficerSanta Rosa, CA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗